vorinostat has been researched along with Alcohol Drinking in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ponomarev, I | 1 |
| Stelly, CE | 1 |
| Morikawa, H | 1 |
| Blednov, YA | 1 |
| Mayfield, RD | 1 |
| Harris, RA | 1 |
1 other study available for vorinostat and Alcohol Drinking
| Article | Year |
|---|---|
Mechanistic insights into epigenetic modulation of ethanol consumption.
Topics: Action Potentials; Alcohol Drinking; Animals; Azacitidine; Behavior, Animal; Binge Drinking; Decitab | 2017 |